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Conclusion: Despite higher risk profile, Japanese women treated with PES tended to
have better clinical outcome than PES-treated men at 1 year.
TCT-418
Bivalirudin Use During Percutaneous Coronary Intervention Improves Clinical
and Economic Outcomes in Diabetic Women
Erin M Galbraith1, Roxana Mehran4, Chandan Devireddy1, Henry A Liberman1,
Steven V Manoukian3, Michele D Voeltz2
1Emory University, Atlanta, GA; 2Henry Ford Hospital, Detroit, MI; 3Sarah Cannon
Research Institute and Hospital Corporation of America, Nashville, TN; 4Mount
Sinai Medical Center, New York, NY
Background: Bivalirudin is associated with superior safety and economic outcomes
with similar efficacy over heparin plus a glycoprotein IIb/IIIa inhibitor (GPI) in
percutaneous intervention (PCI). While gender and diabetes are significant drivers of
clinical and economic outcomes, it is unclear if bivalirudin maintains its advantages
over heparin plus GPI in an unselected group of these high-risk patients.
Methods: Using the Premier Perspective Database, one of the largest administrative
US databases of hospital clinical and economic outcomes, female patients with diabetes
who had undergone PCI between 2004 and 2010 were identified. Primary endpoints
of in-hospital mortality, clinically apparent bleeding, post-PCI length of stay, and
hospitalization costs were compared between patients treated with bivalirudin versus
heparin plus GPI. Data were unadjusted and propensity score matched.
Results: Data from 61,791 diabetic women was examined in the unadjusted population.
Women over 70 years of age and those pre-treated with clopidogrel were more likely
to receive bivalirudin (61% and 64%, respectively; p<0.03); whereas those with STEMI
or shock were more likely to be treated with heparin plus GPI (81% and 78%
respectively; p<0.01). In-hospital mortality and all bleeding parameters were lower in
the bivalirudin group. In contrast, post-PCI length of stay and total adjusted hospital
costs were significantly greater in the heparin group. When a propensity score matching
method was used to minimize baseline differences between comparison groups, all
clinical and economic outcomes remained significantly lower in the bivalirudin-treated
female diabetics, table 1.
“BIV” = Bivalirudin
“HEP + GPI” = Heparin plus glycoprotein IIb/IIIa inhibitor
“PCI” = percutaneous intervention
“US” = United States
Conclusion: In this large population of high-risk patients, real-world bivalirudin use
in diabetic women undergoing PCI is associated with lower rates of in-hospital
mortality, bleeding, transfusion, post-PCI length of stay, and lower hospitalization costs
compared with the use of heparin plus GPI in unadjusted and propensity score matched
populations.
TCT-419
Outcomes of Women after Acute Myocardial Infarction: Results from the
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Background: The impact of gender on the long-term (greater than 1 year) outcomes
of patients with acute myocardial infarction who have undergone primary PCI is not
well established.
Methods: We examined 3 year outcomes from the large-scale, randomized
HORIZONS-AMI trial according to sex. We used Cox proportional-hazards methods
with stepwise selection using entry and exit criteria of p <0.1 to determine the
independent predictors of MACE, major bleeding and death. Candidate variables tested
were sex; age; diabetes; hypertension; history of smoking; prior MI; prior PCI; prior
CABG; Killip class >1; baseline anemia; creatinine; and symptom onset to balloon
time.
Results: Compared with men, women were significantly older and had higher
prevalence of hypertension and hyperlipidemia (all p<0.05). In contrast, women were
less likely to have a prior history of MI, PCI, CABG and were less likely to be smokers
(all p<0.05). Women were less likely to undergo primary PCI in favor of medical
management (p<0.05). They had longer symptom to balloon time (p=0.007). Female
gender was associated with increased MACE, death and major bleeding at 3 year
follow-up (Table). After multivariable analysis female gender remained an independent
predictor of major bleeding, but not of MACE or death.
Patient Outcomes at 3 years
MACE = Major adverse cardiovascular events, composite of death, reinfarction,
stroke, ischemic TVR; CABG= coronary artery bypass graft; TVR = target vessel
revascularization; ST = stent thrombosis
Conclusion: In the HORIZONS-AMI trial, women had a more unfavorable
cardiovascular risk profile compared with men. Female gender was an independent
predictor of long-term major bleeding (HR[95%CI] = 1.77 [1.38, 2.27], P<0.0001, but
not of death (0.92 [0.68, 1.26], P=0.62) or overall MACE (1.17 [0.98, 1.40], P=0.08).
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Background: Although female patients are at high risk for unfavorable outcomes after
STEMI, the independent predictors of major adverse cardiac events (MACE) at long
term follow up have not been described.
Methods: We examined 3-year outcomes of female patients (n=842) from the large-
scale, prospective, multicenter, HORIZONS-AMI trial where patients were randomized
to receive heparin plus glycoprotein IIb/IIIa inhibitor or bivalirudin, and paclitaxel
eluting stents or bare metal stents in a 2 by 2 factorial design. After the performance
of univariate analysis, we used Cox proportional-hazards methods with stepwise
selection using entry and exit criteria of p<0.1 to determine the independent predictors
of MACE, mortality and reinfarction. Candidate variables tested were age,
hypertension, diabetes, history of smoking, peripheral vascular disease, family history
of premature CAD, prior MI, prior PCI, prior CABG, Killip Class on presentation, and
door to balloon time.
Results: The median age was 66 (95% CI 57.1-75.3), 51% were smokers, 19% had
diabetes, 3.3% had chronic renal insufficiency. The 3- year rates of mortality,
reinfarction and MACE were 8.2%, 7.1% and 24% respectively. The table summarizes
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the independent predictors of 3 year adverse events.
Independent Predictors of 3-year MACE, Death and MI in Women
Conclusion: In the HORIZONS-AMI study smoking was an independent predictor of
MACE, death and reinfarction in women after acute myocardial infarction. Diabetes
was a predictor for MACE and reinfarction.
TCT-421
The SPIRIT WOMEN Single Arm Study: Two Year Follow-up Results
Marie-Claude Morice1, Stephan Windecker2, Maria Grazia Modena3, Ghada
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Background: The SPIRIT Women Study provides a characterization of the female
population undergoing stent implantation with emphasis on the evaluation of the safety
and efficacy of the XIENCE V Everolimus Eluting Coronary Stent (EES) (Abbott
Vascular, Santa Clara, USA).
Methods: The SPIRIT Women Single Arm Study is a prospective, open label study
designed to assess outcomes, when EES is used in females in a real-world situation.
Results: A total of 1,572 women with coronary artery disease undergoing percutaneous
coronary intervention were enrolled at 73 international sites between July 2007 and
March 2009. Patients suitable to be treated with up to 4 planned stents, reference vessel
diameter between 2.25 mm and 4.0 mm and lesion length of ≤ 28 mm were eligible,
including patients with acute coronary syndromes. Patients with a previously implanted
stent within the target vessel were excluded. The patient population included 34%
diabetics, 64% and 78% requiring medication for hypercholesterolemia and
hypertension respectively. The mean pre-procedure percent diameter stenosis was 83%
with 29% of lesions ≥ 20mm in length. The mean number of target lesions treated was
1.4. At 1 year, the primary endpoint of all death, myocardial infarction and target vessel
revascularization was 11.9%. One year results included stent thrombosis rate (0.59 %
definite and probable), cardiac death (0.8%), and TLR (2.4%).
Conclusion: This study represents the longest term outcome for EES reported to date
on a large ‘real world’ female population of patients outside of the United States. Two
year follow up rate for the study is 95%. Final adjudication of all clinical events is
ongoing. The 2 year clinical results of the SPIRIT Women Single Arm Study will be
presented and discussed.
TCT-422
Non-atherosclerotic coronary artery disease in young women
Jacqueline Saw, Andrew Starovoytov, John Mancini, Christopher Buller
Cardiology, Vancouver General Hospital, Vancouver, Canada
Background: Non-atherosclerotic CAD (NACAD) is an important cause of MI in
young women, but is often missed on coronary angiography. Our group previously
described the angiographic appearance of coronary fibromuscular dyplasia (FMD), but
the prevalence of this and other NACAD in young women have not been described.
Methods: We retrospectively reviewed all women aged ≤50 who underwent coronary
angiography at Vancouver General Hospital from April 1/2010 to April 30/2011. The
baseline characteristics and medication use were recorded. The angiograms were
reviewed meticulously and reported as normal or mild CAD (<30% stenosis),
atherosclerotic CAD (ACAD), or NACAD. NACAD is further characterized as
coronary dissection, coronary FMD (abrupt transition to diffuse obliterative disease
from a mid to distal coronary artery), ectasia, vasculitis, embolism, congenital anomaly,
or unclear etiology.
Results: Of 4318 coronary angiograms performed, 99 were done in women ≤50. The
mean age was 45±5 (range 31-50), average BMI 27, 19% had diabetes, 37%
dyslipidemia, 40% hypertension, 14% smokers, and 30% had ischemia on stress tests.
The majority (64) had acute coronary syndrome (ACS), and 41 had elevated troponin.
There were 49 with normal or mild CAD (2 Takotsubo cardiomyopathy), and 25 had
ACAD. Twenty (20.2%) had NACAD, of which 14 had coronary dissection or FMD
(13 had ACS). Four had spontaneous coronary dissection: 3 proven on optical
coherence tomography, and a 11 months post-partum retrograde dissection into left
main requiring CABG. Ten had diffuse mid-distal disease consistent with coronary
FMD (could not exclude concurrent coronary dissection), 9 had elevated troponin, and
4 had FMD in another vascular territory. Less common NACAD were suspected
vasculitis in 2 (pulmonary aspergillosis plus eosinophilia, and SLE), and coronary
ectasia in 4 women. Three women with ACS had disease that could not be distinguished
between ACAD or NACAD. Among women with elevated troponin ACS (41/99): 12
(29.3%) had normal or mild CAD (2 Takotsubo), 10 (24.4%) had ACAD, 16 (39.0%)
had NACAD [12 (29.3%) had coronary dissection or FMD, 2 vasculitis, and 2 ectasia],
and 3 had unclear etiology.
Conclusion: Non-atherosclerotic CAD is seen frequently among young women
undergoing coronary angiography, particularly those presenting with MI. Coronary
dissection or FMD is the most commonly encountered NACAD in young women, and
should be better characterized to avoid missed diagnosis.
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Registry
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Background: Although young women are at low risk for developing atherosclerosis,
they may be at high risk for recurrent events once CAD is evident. There are limited
data on medium-term outcomes in young women undergoing PCI.
Methods: We evaluated 3797 women undergoing PCI enrolled in the NHLBI Dynamic
Registry and compared demographic and angiographic data, in-hospital and 1 year
outcomes in women <50 years (n=394) with women ≥50 years old (n=3403).
Results: Compared to women ≥ 50, younger women had lower rates of diabetes (31.9
vs. 38.3%, p=0.01), hypertension (61.4 vs. 79.0%, p<0.001), and hyperlipidemia (62.9
vs. 70.4%, p=0.003) but were more likely to be black (25.6 vs. 15.7%, p<0.001) and
current smokers (52.6 vs. 19.1%, p<0.001). In-hospital adverse event rates for younger
compared to women ≥ 50 were lower or equivalent (death 0.3 vs. 1.5%, p=0.04, MI
1.3 vs. 2.2%, p=0.22, CABG 0.8 vs. 1.0%, p=0.65). Despite less extensive CAD in
younger compared to women ≥ 50 (mean significant lesions 2.2 vs. 2.9, p<0.001),
women <50 were more likely to require repeat revascularization at 1 year (figure).
One-year adjusted relative risks (RR) for younger women using women ≥ 50 as the
reference are: death 0.4 (95% CI 0.2-0.9, p=0.03), CABG 2.2 (95% CI 1.5-3.3,
p<0.001), repeat PCI 1.9 (95% CI 1.5-2.5, p<0.001), and TVR 2.1 (95% CI 1.5-2.8,
p<0.001).
One Year CABG/Repeat PCI Rates for the Dynamic Registry Women
Conclusion: Despite fewer risk factors and less extensive CAD, younger women have
higher repeat revascularization rates after PCI. Plausible explanations include 1) higher
prevalence of smoking, 2) aggressive surveillance or 3) aggressive atherosclerotic and
restenotic phenotypes in young women.
TCT-424
Do Women Continue to have Longer Door-to-Balloon Times in the Era of
STEMI Systems?
Melissa Blondeau, Michel Le May, Derek So, Chris Glover, Michael Froeschl, Jean-
François Marquis, Edward O’Brien, Alexander Dick, Marino Labinaz
University of Ottawa Heart Institute, Ottawa, Canada
Background: Prior studies suggest that women presenting with STEMI have longer
door-to-balloon times. We sought to determine if gender differences persists within the
context of a regional primary PCI program.
Methods: We identified pts referred for Primary PCI from the University of Ottawa
Heart Institute STEMI database. We compared baseline demographics, door-to-balloon
times, and hospital mortality in men and women. Logistic regression analysis was
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